Patents Examined by Bethany Barham
  • Patent number: 9968525
    Abstract: Compositions comprising a gel system made from a combination of a fractal network of nanoparticles and translucent macroscopic particles, titanium dioxide and other color pigments is disclosed. The compositions are capable of forming an effective film on the biological surface such as skin to blurring fine lines and wrinkles while retaining a natural look of the skin as a consequence of synergy between the fractal particles, the macroscopic particles, titanium dioxide and color pigments. Also disclosed methods for their use.
    Type: Grant
    Filed: November 14, 2008
    Date of Patent: May 15, 2018
    Assignee: AVON PRODUCTS, INC.
    Inventors: Ajay G. Dingley, Michael J. Fair, John R. Glynn, Jr., Giovana A. Sandstrom
  • Patent number: 9968533
    Abstract: The present invention describes cosmetic nanotechnology, comprising polymeric nanoparticles containing oil and UV filter, photoprotective compositions comprising polymeric nanoparticles described herein, methods of prevention of diseases of the skin, and processes for the preparation of the polymeric nanoparticles described herein.
    Type: Grant
    Filed: October 9, 2009
    Date of Patent: May 15, 2018
    Assignees: BIOLAB SANUS FARMACÊUTICAL LTDA, UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL—UFRGS
    Inventors: Adriana Raffin Pohlmann, Silvia Stanisçuaski Guterres, Alessandro Jäger
  • Patent number: 9955700
    Abstract: Antimicrobial chemical compositions comprise an aluminum phosphate (AlP) solid dispersed within a binding polymer, wherein one or more bioactive materials are disposed within AlP forming a bioactive-AlP complex. The complex may comprise the bioactive material chemically bonded with the AlP, physically combined with the AlP, or a combination of both. The complex may be formed according to precipitation, condensation and sol-gel methods of forming. The complex is engineered to provide a controlled delivery of the bioactive material or a constituent thereof upon exposure to moisture to give a desired level of antimicrobial resistance to a film or composite formed from the composition of at least about 30 ?g/m2, and may also provide a desired degree of corrosion resistance through the release of passivating phosphate anion.
    Type: Grant
    Filed: October 13, 2015
    Date of Patent: May 1, 2018
    Assignee: BUNGE AMORPHIC SOLUTIONS LLC
    Inventor: Raymond E. Foscante
  • Patent number: 9907804
    Abstract: Disclosed are compounds of general formula (I): and pharmaceutically acceptable salts thereof, formulations, methods and uses in, for example, the treatment of disease.
    Type: Grant
    Filed: February 29, 2016
    Date of Patent: March 6, 2018
    Assignee: WISTA LABORATORIES LTD.
    Inventors: Colin Marshall, Scott Clunas, John Mervyn David Storey, James Peter Sinclair, Thomas Craven Baddeley, Ahtsham Ishaq, Michael Simpson, Craig Williamson, Barry Alan Wood, Claude Michel Wischik, Charles Robert Harrington, Janet Elizabeth Rickard, David Horsley, Yin Sze Loh, Karrar Ahmad Khan, Christopher Paul Larch
  • Patent number: 9901649
    Abstract: Amphiphilic block copolymers (BCPs) were prepared comprising a poly(ethylene oxide) block and a biodegradable polycarbonate block functionalized with disulfide groups and carboxylic acid groups. The BCPs form self-assembled micellar particles in aqueous solution that can be loaded with hydrophobic drugs for therapeutic drug delivery. The loaded particles have small particle sizes (<100 nm), narrow particle size distributions, and high drug loading capacity (up to about 50 wt %) based on total dry weight of the loaded particles. Particles loaded with DOX released the DOX in response to changes in pH and glutathione (GSH) redox chemistry. The loaded particles efficiently delivered and released DOX within tumor cells, effectively suppressing growth of the tumor cells at a similar or even lower drug concentration than free DOX. Blank particles containing no DOX did not induce cytotoxicity to cells.
    Type: Grant
    Filed: May 3, 2016
    Date of Patent: February 27, 2018
    Assignees: International Business Machines Corporation, Agency For Science, Technology and Research
    Inventors: Willy Chin, Yukti Choudhury, Shujun Gao, James L. Hedrick, Xiyu Ke, Min-Han Tan, Jye Yng Teo, Yi Yan Yang
  • Patent number: 9884009
    Abstract: Provided is a moisturizing, anti-wrinkle, and anti-allergic traditional Chinese medicine composition and a preparation method thereof. The traditional Chinese medicine composition has an aqueous extract of Dendrobium nobile, Viola tricolor, Ophiopogon japonicus, Tremella fuciformis, and an oat material as active ingredient. The oat material is oat grains, oat flour, or oat bran. In the composition, the Dendrobium nobile, Viola tricolor, Ophiopogon japonicus, Tremella fuciformis and oat material have a weight ratio of 5-15:2-10:2-10:1-5:1-5, and preferably 12:6:3:2:2. The Dendrobium nobile, Viola tricolor, Ophiopogon japonicus, oat material, and Tremella fuciformis are combined and extracted for external use, with which moisturizing and also delaying skin aging, anti-allergic and anti-chapping efficacies are achieved by means of water retention, maintenance of normal physiological functions of aquaporins, and others.
    Type: Grant
    Filed: May 9, 2014
    Date of Patent: February 6, 2018
    Assignee: INFINITUS (CHINA) CO., LTD
    Inventors: Guangrong Liu, Zidan Li
  • Patent number: 9861097
    Abstract: Composite materials that are palatable to a wood-destroying pest species and also pesticidal to the pest species can be used in pest control devices and can be used as wood substitutes for structural components, which are resistant to destruction by wood-destroying pests. The composite materials include a thermoplastic polymer, a food material for the pest and a pesticide. The composite material is formed by mixing a thermoplastic polymer, wood fragments or other cellulosic materials and a quantity of pesticide, and thereafter creating a molten material within a mixer, compounder, extruder or the like. The molten material is extruded or molded to form the desired shape.
    Type: Grant
    Filed: July 2, 2015
    Date of Patent: January 9, 2018
    Assignee: Dow AgroSciences LLC
    Inventors: Robert L. Hill, James E. King, Joseph J. DeMark, Anton Arnoldy, Mike P. Tolley, Donald E. Williams, III, Joseph E. Eger, Jr.
  • Patent number: 9861629
    Abstract: Described herein are oral abuse deterrent pharmaceutical compositions, methods for making the same, and methods for treating pain by administering the pharmaceutical composition to a subject in need thereof. In particular, an oral abuse deterrent pharmaceutical composition comprising a soft capsule and a controlled release matrix comprising oxycodone are described.
    Type: Grant
    Filed: October 5, 2016
    Date of Patent: January 9, 2018
    Assignee: Banner Life Sciences LLC
    Inventors: Justin Hughey, Saujanya Gosangari, Chue Hue Yang
  • Patent number: 9855292
    Abstract: The current invention discloses novel approaches to help individuals defend against headaches and body pains with orally-delivered cyanocobalamin, methylcobalamin, adenosylcobalamin, and combinations thereof. Original clinical research conducted by the inventor on almost 2,000 humans yielded surprising and unexpected results showing differences in the frequency and severity of pains in the head and the body favoring cyanocobalamin patients over placebo. In one FDA-approved Phase III study on 1,551 patients, 4.4 percent of headaches and body pains were rated as “Severe” in the cyanocobalamin, group versus 11.5 percent in the placebo group. Once inside the body, cyanocobalamin is converted to methylcobalamin and adenosylcobalamin, but not to hydroxocobalamin.
    Type: Grant
    Filed: August 7, 2013
    Date of Patent: January 2, 2018
    Inventor: Ernest Timothy Armstrong
  • Patent number: 9849142
    Abstract: Methods of treatment and dosage regimes using hydrophobic gel or foam compositions comprising a tetracycline antibiotic for accelerating the return of skin integrity and or in treating or alleviating a disorder including impetigo, acne, rosacea, a skin disease caused by a bacteria or a tetracycline antibiotic responsive disease, wherein the foam composition or gel is administered topically to a target area on a subject having the disorder and wherein the target area comprises an area of skin, or mucosa or an eye.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: December 26, 2017
    Assignee: Foamix Pharmaceuticals Ltd.
    Inventors: Dov Tamarkin, Elana Gazal, Rita Keynan, Meir Eini, David Schuz
  • Patent number: 9849121
    Abstract: An aqueous liquid preparation containing (+)-(S)-4-[4-[(4-chlorophenyl)(2-pyridyl)methoxy]piperidino]butyric acid or a pharmacologically acceptable acid addition salt thereof, which is stabilized with a water-soluble metal chloride, is provided.
    Type: Grant
    Filed: October 10, 2014
    Date of Patent: December 26, 2017
    Assignee: SENJU PHARMACEUTICAL CO., LTD.
    Inventor: Masayo Higashiyama
  • Patent number: 9833405
    Abstract: The present invention provides a biodegradable microdepot delivery system for topical delivery of active ingredients through the skin surface of a subject. The configuration, dimension, and chemical composition of the microdepots allow a relatively short dissolution time of less than 5 minutes while insertion ratio of the microdepots can reach more than 60%, some of which can even reach about 97%, under exertion of a relatively low pressing force. The present invention also provides a method for fabricating the biodegradable microdepot delivery system and a polymeric solution for forming the same.
    Type: Grant
    Filed: March 13, 2015
    Date of Patent: December 5, 2017
    Assignee: Nano and Advanced Materials Institute Limited
    Inventors: Jinjie Xu, Ho Wang Tong, Sau Kuen Connie Kwok, Ngar Yee Huen
  • Patent number: 9833508
    Abstract: The invention relates to the treatment of cancer. In one embodiment, the present invention provides a composition comprising a micelle construct attached to a glut-1 antibody and a curcumin molecule. In another embodiment, the present invention provides a method of treating colon and/or breast cancer by administering a therapeutically effective amount of composition comprising a targeted construct attached to an inhibitor of NF-kB.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: December 5, 2017
    Assignee: Immix Biopharma, Inc.
    Inventors: Sean Senn, Ilya Rachman
  • Patent number: 9827323
    Abstract: Disclosed are compositions comprising collagen covalently bound to particles, wherein covalent bonds are formed between reactive groups of the collagen and reactive groups of the particles, and wherein the particles have an average particle diameter ranging from 20 to 1000 nanometers. Also disclosed are various methods that utilize the compositions.
    Type: Grant
    Filed: June 7, 2011
    Date of Patent: November 28, 2017
    Assignee: THE CURATORS OF THE UNIVERSITY OF MISSOURI
    Inventors: Anthony Harris, Johnathan Thompson, Rebecca Rone, Sheila Grant, David Grant
  • Patent number: 9826742
    Abstract: The invention relates to an octanoic, nonanoic and decanoic (C8, 9, 10) fatty acids mixture with a pyrethroid. The invention also relates to methods of using the octanoic, nonanoic and decanoic (C8, 9, 10) fatty acids and pyrethroid mixture to achieve superior arthropod control.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: November 28, 2017
    Assignee: VALENT BIOSCIENCES CORPORATION
    Inventors: Benjamin A. Belkind, Jason Clark, Peter DeChant
  • Patent number: 9808468
    Abstract: Unit dosage forms of meloxicam containing either 5 mg or 10 mg of meloxicam that provide effective pain relief and have desirable pharmacokinetic properties are described. The unit dosage forms can provide pain relief when a single unit dose is administered to a patient and useful for treating pain such as osteoarthritis pain at a relatively low systemic exposure to meloxicam.
    Type: Grant
    Filed: May 15, 2017
    Date of Patent: November 7, 2017
    Assignee: iCeutica Pty Ltd.
    Inventor: H. William Bosch
  • Patent number: 9801793
    Abstract: The present technology provides a dry shampoo composition comprising clay, natural starches and a natural oil absorbent. Such dry shampoo compositions are highly absorbent, fine, light and resistant to clumping. In some embodiments, the dry shampoo compositions are useful as alternatives to conventional wet shampoo in methods for cleaning hair.
    Type: Grant
    Filed: March 29, 2016
    Date of Patent: October 31, 2017
    Assignee: HERB UK LIMITED
    Inventors: Raoul John Perfitt, Cicely Andrea Ruth Carimbocas
  • Patent number: 9801797
    Abstract: Cosmetic formulations including specific ester quats based on isopropanolamine are provided, as well as the use of these ester quats in cosmetics.
    Type: Grant
    Filed: March 21, 2014
    Date of Patent: October 31, 2017
    Assignee: EVONIK DEGUSSA GMBH
    Inventors: Hans-Juergen Koehle, Kurt Seidel, Peter Schwab, Ursula Westerholt
  • Patent number: 9801896
    Abstract: Provided herein are compositions and formulations comprising S-adenosyl-L-methionine (“SAM-e” or “SAMe”) and one or more gallic acid esters. Also provided herein are methods for improving the delivery of SAMe. Compositions and formulations provided herein increase SAMe plasma concentrations and area under the curve (AUC) values. Also provided herein are methods of treating a disease or disorder in a subject by administering compositions or formulations comprising exogenous SAMe and one or more gallic acid esters.
    Type: Grant
    Filed: October 16, 2013
    Date of Patent: October 31, 2017
    Assignee: METHYLATION SCIENCES INTERNATIONAL SRL
    Inventors: Dechi Guan, I. David MacDonald
  • Patent number: 9801385
    Abstract: Antimicrobial chemical compositions comprise an aluminum phosphate (AlP) solid dispersed within a binding polymer, wherein one or more bioactive materials are disposed within AlP forming a bioactive-AlP complex. The complex may comprise the bioactive material chemically bonded with the AlP, physically combined with the AlP, or a combination of both. The complex may be formed according to precipitation, condensation and sol-gel methods of forming. The complex is engineered to provide a controlled delivery of the bioactive material or a constituent thereof upon exposure to moisture to give a desired level of antimicrobial resistance to a film or composite formed from the composition of at least about 30 ?g/m2, and may also provide a desired degree of corrosion resistance through the release of passivating phosphate anion.
    Type: Grant
    Filed: July 14, 2015
    Date of Patent: October 31, 2017
    Assignee: Bunge Amorphic Solutions LLC
    Inventor: Raymond E. Foscante